Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cross Infection | 151 | 2023 | 304 | 16.080 |
Why?
|
Staphylococcal Infections | 47 | 2023 | 176 | 8.420 |
Why?
|
Infection Control | 78 | 2021 | 174 | 8.160 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 35 | 2023 | 124 | 7.580 |
Why?
|
Anti-Bacterial Agents | 81 | 2023 | 401 | 7.430 |
Why?
|
Intensive Care Units | 62 | 2023 | 312 | 4.560 |
Why?
|
Bacteremia | 35 | 2019 | 117 | 4.490 |
Why?
|
Humans | 330 | 2023 | 29811 | 3.130 |
Why?
|
Drug Resistance, Bacterial | 18 | 2021 | 52 | 2.920 |
Why?
|
Enterococcus | 26 | 2014 | 57 | 2.770 |
Why?
|
Klebsiella pneumoniae | 20 | 2022 | 61 | 2.720 |
Why?
|
Community-Acquired Infections | 21 | 2022 | 78 | 2.710 |
Why?
|
Drug Resistance, Microbial | 44 | 2015 | 96 | 2.670 |
Why?
|
Klebsiella Infections | 18 | 2022 | 56 | 2.610 |
Why?
|
Chlorhexidine | 20 | 2023 | 61 | 2.550 |
Why?
|
Enterobacteriaceae Infections | 22 | 2021 | 38 | 2.410 |
Why?
|
Gram-Positive Bacterial Infections | 22 | 2014 | 58 | 2.300 |
Why?
|
Disease Outbreaks | 31 | 2023 | 89 | 2.270 |
Why?
|
Catheterization, Central Venous | 17 | 2014 | 42 | 2.140 |
Why?
|
Anti-Infective Agents | 14 | 2023 | 63 | 2.120 |
Why?
|
Chicago | 48 | 2021 | 866 | 2.080 |
Why?
|
Hospitals | 36 | 2023 | 157 | 2.050 |
Why?
|
Carbapenems | 11 | 2021 | 31 | 2.050 |
Why?
|
beta-Lactamases | 19 | 2023 | 72 | 1.940 |
Why?
|
Carrier State | 20 | 2019 | 52 | 1.930 |
Why?
|
Surgical Wound Infection | 13 | 2019 | 98 | 1.910 |
Why?
|
Bacterial Proteins | 17 | 2021 | 76 | 1.870 |
Why?
|
Population Surveillance | 15 | 2018 | 118 | 1.850 |
Why?
|
Anti-Infective Agents, Local | 16 | 2023 | 52 | 1.790 |
Why?
|
Male | 133 | 2023 | 15850 | 1.780 |
Why?
|
Staphylococcus aureus | 18 | 2023 | 85 | 1.760 |
Why?
|
AIDS-Related Opportunistic Infections | 19 | 2010 | 46 | 1.750 |
Why?
|
Baths | 11 | 2023 | 27 | 1.740 |
Why?
|
Female | 129 | 2023 | 16410 | 1.680 |
Why?
|
Drug Resistance, Multiple, Bacterial | 17 | 2020 | 41 | 1.670 |
Why?
|
Enterobacteriaceae | 17 | 2020 | 30 | 1.620 |
Why?
|
Hand Disinfection | 14 | 2019 | 24 | 1.600 |
Why?
|
Methicillin Resistance | 10 | 2012 | 31 | 1.540 |
Why?
|
Hospitalization | 20 | 2021 | 319 | 1.540 |
Why?
|
Adult | 90 | 2023 | 8741 | 1.530 |
Why?
|
Vancomycin Resistance | 14 | 2014 | 29 | 1.520 |
Why?
|
Vancomycin | 15 | 2012 | 58 | 1.520 |
Why?
|
Practice Guidelines as Topic | 13 | 2018 | 334 | 1.490 |
Why?
|
Pneumonia, Pneumocystis | 19 | 2010 | 32 | 1.460 |
Why?
|
Carbapenem-Resistant Enterobacteriaceae | 7 | 2021 | 13 | 1.450 |
Why?
|
Bacterial Infections | 12 | 2021 | 66 | 1.430 |
Why?
|
HIV Infections | 14 | 2013 | 997 | 1.430 |
Why?
|
Middle Aged | 97 | 2023 | 9960 | 1.410 |
Why?
|
Risk Factors | 39 | 2021 | 2465 | 1.190 |
Why?
|
Equipment Contamination | 12 | 2019 | 26 | 1.140 |
Why?
|
Probiotics | 2 | 2018 | 20 | 1.140 |
Why?
|
Gloves, Protective | 7 | 2019 | 15 | 1.140 |
Why?
|
Medical Staff, Hospital | 3 | 2017 | 19 | 1.130 |
Why?
|
Sepsis | 11 | 2023 | 147 | 1.120 |
Why?
|
Communicable Diseases | 5 | 2023 | 24 | 1.110 |
Why?
|
Prevalence | 20 | 2023 | 494 | 1.080 |
Why?
|
Skin | 12 | 2018 | 118 | 1.080 |
Why?
|
Internal Medicine | 3 | 2017 | 32 | 1.070 |
Why?
|
Aged | 67 | 2023 | 9620 | 1.050 |
Why?
|
Clostridium Infections | 4 | 2018 | 19 | 1.040 |
Why?
|
Genomics | 8 | 2022 | 43 | 1.000 |
Why?
|
Gram-Negative Bacterial Infections | 9 | 2015 | 24 | 1.000 |
Why?
|
Alveolar Bone Loss | 4 | 2013 | 5 | 1.000 |
Why?
|
Guideline Adherence | 8 | 2014 | 67 | 0.990 |
Why?
|
United States | 43 | 2023 | 2344 | 0.970 |
Why?
|
Illinois | 13 | 2021 | 241 | 0.940 |
Why?
|
Microbial Sensitivity Tests | 29 | 2023 | 110 | 0.940 |
Why?
|
Catheter-Related Infections | 7 | 2023 | 28 | 0.910 |
Why?
|
Antibiotic Prophylaxis | 5 | 2016 | 37 | 0.860 |
Why?
|
Drug Utilization | 8 | 2009 | 27 | 0.850 |
Why?
|
Catheters, Indwelling | 7 | 2006 | 26 | 0.820 |
Why?
|
Drug Utilization Review | 3 | 2009 | 7 | 0.810 |
Why?
|
Catheterization | 8 | 2007 | 51 | 0.800 |
Why?
|
Mass Screening | 4 | 2015 | 180 | 0.800 |
Why?
|
Molecular Typing | 4 | 2021 | 7 | 0.790 |
Why?
|
Prisons | 3 | 2013 | 12 | 0.790 |
Why?
|
Q Fever | 2 | 2016 | 4 | 0.770 |
Why?
|
Physicians | 6 | 2016 | 116 | 0.770 |
Why?
|
Hand | 6 | 2008 | 46 | 0.740 |
Why?
|
Personnel, Hospital | 7 | 2009 | 18 | 0.740 |
Why?
|
Influenza, Human | 1 | 2021 | 46 | 0.730 |
Why?
|
Tuberculosis, Pulmonary | 5 | 2009 | 8 | 0.730 |
Why?
|
Prospective Studies | 31 | 2023 | 1823 | 0.730 |
Why?
|
Adolescent | 28 | 2022 | 2332 | 0.720 |
Why?
|
Protective Clothing | 3 | 2019 | 10 | 0.720 |
Why?
|
Health Care Costs | 3 | 2010 | 70 | 0.700 |
Why?
|
Sexual and Gender Minorities | 1 | 2020 | 25 | 0.700 |
Why?
|
Cost-Benefit Analysis | 4 | 2015 | 143 | 0.700 |
Why?
|
Long-Term Care | 11 | 2019 | 56 | 0.700 |
Why?
|
DNA, Bacterial | 9 | 2019 | 49 | 0.690 |
Why?
|
Ventilation | 2 | 2017 | 4 | 0.690 |
Why?
|
Public Health | 3 | 2019 | 61 | 0.690 |
Why?
|
Retrospective Studies | 30 | 2022 | 3325 | 0.680 |
Why?
|
Case-Control Studies | 14 | 2023 | 641 | 0.680 |
Why?
|
Evolution, Molecular | 2 | 2017 | 7 | 0.670 |
Why?
|
Quality of Health Care | 7 | 2005 | 138 | 0.670 |
Why?
|
Models, Economic | 3 | 2010 | 9 | 0.670 |
Why?
|
Pseudomonas Infections | 14 | 2017 | 60 | 0.670 |
Why?
|
Patient Isolation | 8 | 2010 | 23 | 0.670 |
Why?
|
Genotype | 4 | 2019 | 399 | 0.670 |
Why?
|
Smoke | 1 | 2018 | 3 | 0.660 |
Why?
|
Dental Implantation, Endosseous | 3 | 2017 | 3 | 0.640 |
Why?
|
Conflict of Interest | 1 | 2018 | 18 | 0.640 |
Why?
|
Hospitals, Teaching | 10 | 2018 | 33 | 0.640 |
Why?
|
Mupirocin | 6 | 2023 | 17 | 0.630 |
Why?
|
Antimicrobial Stewardship | 2 | 2018 | 10 | 0.620 |
Why?
|
Catheterization, Peripheral | 4 | 2002 | 15 | 0.610 |
Why?
|
Primary Prevention | 1 | 2018 | 39 | 0.610 |
Why?
|
Gram-Negative Bacteria | 12 | 2013 | 37 | 0.610 |
Why?
|
Acquired Immunodeficiency Syndrome | 8 | 2006 | 92 | 0.610 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 3 | 2008 | 6 | 0.600 |
Why?
|
Genome, Bacterial | 5 | 2017 | 14 | 0.590 |
Why?
|
Medical Audit | 1 | 2017 | 7 | 0.590 |
Why?
|
Hospital Costs | 3 | 2014 | 68 | 0.590 |
Why?
|
Inappropriate Prescribing | 1 | 2017 | 6 | 0.590 |
Why?
|
Nursing Homes | 7 | 2020 | 38 | 0.580 |
Why?
|
Hospitals, Public | 11 | 2015 | 31 | 0.580 |
Why?
|
Bacterial Typing Techniques | 3 | 2016 | 12 | 0.580 |
Why?
|
Acinetobacter Infections | 3 | 2019 | 5 | 0.570 |
Why?
|
Patient Care | 3 | 2013 | 34 | 0.570 |
Why?
|
Registries | 3 | 2022 | 191 | 0.560 |
Why?
|
Nasal Cavity | 4 | 2014 | 35 | 0.560 |
Why?
|
Cesarean Section | 1 | 2016 | 30 | 0.550 |
Why?
|
Escherichia coli | 8 | 2023 | 61 | 0.550 |
Why?
|
Time Factors | 21 | 2022 | 1641 | 0.540 |
Why?
|
Acinetobacter baumannii | 2 | 2019 | 4 | 0.540 |
Why?
|
Length of Stay | 6 | 2014 | 320 | 0.540 |
Why?
|
Drug Resistance, Multiple | 6 | 2012 | 12 | 0.540 |
Why?
|
Lactobacillus | 1 | 2016 | 20 | 0.540 |
Why?
|
Critical Care | 8 | 2018 | 242 | 0.540 |
Why?
|
Doxycycline | 1 | 2016 | 20 | 0.530 |
Why?
|
State Medicine | 1 | 2015 | 2 | 0.530 |
Why?
|
Child | 17 | 2023 | 1377 | 0.530 |
Why?
|
Pneumonia, Ventilator-Associated | 5 | 2023 | 17 | 0.530 |
Why?
|
Aerosols | 3 | 2013 | 20 | 0.530 |
Why?
|
Health Information Exchange | 1 | 2015 | 5 | 0.530 |
Why?
|
Health Personnel | 4 | 2021 | 114 | 0.520 |
Why?
|
Health Resources | 2 | 2010 | 24 | 0.510 |
Why?
|
Delivery of Health Care | 6 | 2023 | 156 | 0.500 |
Why?
|
Anesthesia | 1 | 2015 | 35 | 0.490 |
Why?
|
Anesthesiology | 1 | 2015 | 30 | 0.490 |
Why?
|
Urban Population | 3 | 2021 | 143 | 0.480 |
Why?
|
Pharynx | 1 | 2014 | 14 | 0.480 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 12 | 2015 | 39 | 0.470 |
Why?
|
Medical Records Systems, Computerized | 3 | 2009 | 12 | 0.470 |
Why?
|
Urinary Tract Infections | 6 | 2023 | 32 | 0.470 |
Why?
|
Specimen Handling | 5 | 2017 | 50 | 0.470 |
Why?
|
Bacteria | 7 | 2017 | 76 | 0.470 |
Why?
|
Sequence Analysis, DNA | 5 | 2017 | 73 | 0.470 |
Why?
|
Platelet-Rich Plasma | 2 | 2016 | 75 | 0.470 |
Why?
|
Pneumococcal Vaccines | 2 | 2004 | 5 | 0.450 |
Why?
|
Program Evaluation | 3 | 2009 | 135 | 0.450 |
Why?
|
Communicable Disease Control | 6 | 2023 | 15 | 0.440 |
Why?
|
Air Microbiology | 1 | 2013 | 3 | 0.440 |
Why?
|
Fungi | 1 | 2013 | 5 | 0.440 |
Why?
|
Fluoroquinolones | 4 | 2023 | 25 | 0.430 |
Why?
|
Disease Transmission, Infectious | 5 | 2019 | 21 | 0.420 |
Why?
|
Disease Notification | 2 | 2018 | 4 | 0.420 |
Why?
|
Molecular Epidemiology | 9 | 2021 | 26 | 0.410 |
Why?
|
Students, Medical | 1 | 2012 | 44 | 0.410 |
Why?
|
Staphylococcal Skin Infections | 3 | 2011 | 14 | 0.410 |
Why?
|
Phenotype | 8 | 2021 | 362 | 0.410 |
Why?
|
Cephalosporins | 9 | 2019 | 17 | 0.400 |
Why?
|
Emergency Medical Services | 2 | 2014 | 34 | 0.400 |
Why?
|
Costs and Cost Analysis | 4 | 2010 | 36 | 0.400 |
Why?
|
Multivariate Analysis | 12 | 2013 | 332 | 0.400 |
Why?
|
Tertiary Care Centers | 4 | 2019 | 67 | 0.400 |
Why?
|
Pharmacy Service, Hospital | 4 | 2006 | 9 | 0.400 |
Why?
|
Child, Preschool | 9 | 2023 | 654 | 0.390 |
Why?
|
Streptococcal Infections | 2 | 2002 | 14 | 0.390 |
Why?
|
Water Microbiology | 3 | 2020 | 10 | 0.380 |
Why?
|
Guidelines as Topic | 5 | 2009 | 69 | 0.380 |
Why?
|
Hospital Mortality | 8 | 2010 | 140 | 0.380 |
Why?
|
Skilled Nursing Facilities | 4 | 2021 | 20 | 0.380 |
Why?
|
Gingival Recession | 1 | 2010 | 1 | 0.380 |
Why?
|
Furcation Defects | 1 | 2010 | 1 | 0.380 |
Why?
|
Evidence-Based Dentistry | 1 | 2010 | 1 | 0.380 |
Why?
|
Antiretroviral Therapy, Highly Active | 4 | 2010 | 146 | 0.380 |
Why?
|
Pandemics | 3 | 2023 | 237 | 0.370 |
Why?
|
Infant | 9 | 2021 | 541 | 0.370 |
Why?
|
Cohort Studies | 15 | 2023 | 1952 | 0.370 |
Why?
|
Disinfectants | 3 | 2014 | 8 | 0.370 |
Why?
|
Medical Records | 4 | 2005 | 33 | 0.370 |
Why?
|
Medicaid | 3 | 2006 | 37 | 0.360 |
Why?
|
HIV Seropositivity | 2 | 2004 | 95 | 0.360 |
Why?
|
Jaw, Edentulous | 1 | 2010 | 1 | 0.360 |
Why?
|
Dental Prosthesis, Implant-Supported | 1 | 2010 | 1 | 0.360 |
Why?
|
Immediate Dental Implant Loading | 1 | 2010 | 1 | 0.360 |
Why?
|
Alcohols | 5 | 2007 | 7 | 0.360 |
Why?
|
Algorithms | 6 | 2014 | 400 | 0.360 |
Why?
|
Housekeeping, Hospital | 2 | 2008 | 5 | 0.360 |
Why?
|
Mandible | 1 | 2010 | 15 | 0.360 |
Why?
|
Tuberculosis, Multidrug-Resistant | 2 | 2000 | 2 | 0.350 |
Why?
|
Hospital Information Systems | 2 | 2014 | 5 | 0.350 |
Why?
|
Pseudomonas aeruginosa | 14 | 2017 | 79 | 0.340 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2008 | 193 | 0.340 |
Why?
|
DNA Fingerprinting | 3 | 2016 | 6 | 0.340 |
Why?
|
Pharmacists | 2 | 2006 | 16 | 0.340 |
Why?
|
Hospitals, Urban | 8 | 2015 | 35 | 0.340 |
Why?
|
Respiration, Artificial | 7 | 2015 | 109 | 0.340 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 11 | 0.340 |
Why?
|
Occupational Diseases | 1 | 2009 | 20 | 0.330 |
Why?
|
Soft Tissue Infections | 3 | 2011 | 28 | 0.330 |
Why?
|
Rectum | 7 | 2017 | 61 | 0.320 |
Why?
|
Ambulatory Care | 2 | 2006 | 78 | 0.320 |
Why?
|
Ceftazidime | 7 | 2001 | 13 | 0.320 |
Why?
|
Feces | 4 | 2017 | 97 | 0.320 |
Why?
|
Acinetobacter | 1 | 2008 | 2 | 0.310 |
Why?
|
Decontamination | 4 | 2008 | 9 | 0.310 |
Why?
|
Disinfection | 3 | 2019 | 11 | 0.310 |
Why?
|
Escherichia coli Infections | 6 | 2014 | 29 | 0.310 |
Why?
|
Plasmids | 7 | 2023 | 44 | 0.310 |
Why?
|
Young Adult | 8 | 2022 | 1966 | 0.300 |
Why?
|
Infant, Newborn | 9 | 2021 | 618 | 0.300 |
Why?
|
Drug Contamination | 3 | 2001 | 7 | 0.300 |
Why?
|
Skin Care | 4 | 2018 | 14 | 0.300 |
Why?
|
Incidence | 11 | 2013 | 759 | 0.300 |
Why?
|
Public Housing | 1 | 2007 | 4 | 0.300 |
Why?
|
Aged, 80 and over | 19 | 2023 | 4930 | 0.290 |
Why?
|
Developing Countries | 2 | 2005 | 21 | 0.290 |
Why?
|
Penicillins | 3 | 2002 | 12 | 0.290 |
Why?
|
Pneumonia | 5 | 1998 | 67 | 0.290 |
Why?
|
Amikacin | 4 | 1998 | 7 | 0.290 |
Why?
|
Ciprofloxacin | 5 | 2003 | 28 | 0.290 |
Why?
|
Hospital Administration | 3 | 2021 | 24 | 0.290 |
Why?
|
Serratia Infections | 2 | 2010 | 10 | 0.290 |
Why?
|
Attitude of Health Personnel | 5 | 2021 | 149 | 0.290 |
Why?
|
Education, Medical | 1 | 2007 | 48 | 0.280 |
Why?
|
Hospital Units | 2 | 2004 | 9 | 0.280 |
Why?
|
Phylogeny | 4 | 2023 | 63 | 0.280 |
Why?
|
Enterobacter | 8 | 2001 | 8 | 0.280 |
Why?
|
Bacteriological Techniques | 6 | 2017 | 20 | 0.280 |
Why?
|
Drug Therapy, Combination | 5 | 2011 | 245 | 0.280 |
Why?
|
Referral and Consultation | 4 | 2007 | 85 | 0.280 |
Why?
|
Cost of Illness | 1 | 2006 | 55 | 0.280 |
Why?
|
Ventilators, Mechanical | 3 | 2021 | 21 | 0.270 |
Why?
|
Rifampin | 1 | 2006 | 7 | 0.270 |
Why?
|
Silver | 1 | 2006 | 4 | 0.270 |
Why?
|
Minocycline | 1 | 2006 | 8 | 0.270 |
Why?
|
Enterococcus faecium | 4 | 2001 | 15 | 0.270 |
Why?
|
Problem-Based Learning | 1 | 2006 | 7 | 0.270 |
Why?
|
Nose | 3 | 2013 | 35 | 0.270 |
Why?
|
Information Services | 1 | 2005 | 3 | 0.260 |
Why?
|
Daptomycin | 1 | 2005 | 13 | 0.260 |
Why?
|
Research | 1 | 2006 | 55 | 0.260 |
Why?
|
Treatment Outcome | 14 | 2018 | 3561 | 0.260 |
Why?
|
Dental Implants | 2 | 2017 | 8 | 0.260 |
Why?
|
Gastrointestinal Microbiome | 2 | 2019 | 181 | 0.260 |
Why?
|
Education, Medical, Continuing | 1 | 2006 | 45 | 0.260 |
Why?
|
Pneumonia, Bacterial | 3 | 2017 | 10 | 0.260 |
Why?
|
Culture Media | 5 | 2017 | 36 | 0.250 |
Why?
|
Nursing Records | 1 | 2005 | 9 | 0.250 |
Why?
|
Gram-Negative Aerobic Bacteria | 3 | 2005 | 4 | 0.250 |
Why?
|
Community Health Centers | 1 | 2005 | 12 | 0.250 |
Why?
|
Quality Indicators, Health Care | 1 | 2005 | 39 | 0.250 |
Why?
|
Subacute Care | 2 | 2021 | 5 | 0.250 |
Why?
|
Streptococcus pneumoniae | 2 | 2002 | 6 | 0.250 |
Why?
|
Dental Plaque | 1 | 2004 | 1 | 0.250 |
Why?
|
Mouthwashes | 1 | 2004 | 6 | 0.250 |
Why?
|
Communicable Diseases, Emerging | 1 | 2004 | 2 | 0.240 |
Why?
|
Bacterial Load | 3 | 2013 | 13 | 0.240 |
Why?
|
Masks | 2 | 2021 | 3 | 0.240 |
Why?
|
Dental Enamel Proteins | 1 | 2004 | 1 | 0.230 |
Why?
|
Natural Language Processing | 1 | 2003 | 2 | 0.230 |
Why?
|
Health Behavior | 2 | 2021 | 159 | 0.230 |
Why?
|
Vaccination | 1 | 2004 | 41 | 0.230 |
Why?
|
Coxiella burnetii | 1 | 2003 | 3 | 0.230 |
Why?
|
Hospitals, University | 3 | 2015 | 40 | 0.230 |
Why?
|
Radiography, Thoracic | 1 | 2003 | 28 | 0.230 |
Why?
|
Bioterrorism | 1 | 2003 | 6 | 0.230 |
Why?
|
Iodophors | 1 | 2023 | 2 | 0.230 |
Why?
|
Diarrhea | 2 | 2008 | 47 | 0.230 |
Why?
|
Radiology | 1 | 2003 | 22 | 0.230 |
Why?
|
Unnecessary Procedures | 1 | 2004 | 24 | 0.230 |
Why?
|
Colony Count, Microbial | 6 | 2015 | 23 | 0.230 |
Why?
|
Vancomycin-Resistant Enterococci | 2 | 2020 | 5 | 0.230 |
Why?
|
Point-of-Care Systems | 1 | 2004 | 53 | 0.230 |
Why?
|
Arizona | 1 | 2023 | 5 | 0.220 |
Why?
|
Databases as Topic | 1 | 2003 | 19 | 0.220 |
Why?
|
Technology | 1 | 2023 | 6 | 0.220 |
Why?
|
Digestive System Diseases | 1 | 2003 | 4 | 0.220 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2003 | 81 | 0.220 |
Why?
|
Computers | 1 | 2003 | 26 | 0.220 |
Why?
|
Text Messaging | 1 | 2023 | 14 | 0.220 |
Why?
|
Nursing Staff, Hospital | 1 | 2003 | 61 | 0.220 |
Why?
|
Patient Care Team | 3 | 2010 | 141 | 0.220 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2017 | 57 | 0.220 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2002 | 16 | 0.220 |
Why?
|
Critical Illness | 4 | 2018 | 127 | 0.220 |
Why?
|
Infusions, Intravenous | 2 | 2005 | 78 | 0.220 |
Why?
|
Gels | 1 | 2002 | 11 | 0.220 |
Why?
|
Hospitals, Private | 1 | 2002 | 2 | 0.220 |
Why?
|
Hospitals, County | 1 | 2002 | 4 | 0.220 |
Why?
|
Renal Insufficiency | 1 | 2002 | 13 | 0.220 |
Why?
|
Water Supply | 1 | 2002 | 4 | 0.210 |
Why?
|
Gentamicins | 5 | 1995 | 16 | 0.210 |
Why?
|
Medication Systems | 1 | 2002 | 2 | 0.210 |
Why?
|
Intestines | 3 | 2007 | 108 | 0.210 |
Why?
|
Patient Transfer | 2 | 2012 | 20 | 0.210 |
Why?
|
Penicillin Resistance | 1 | 2002 | 1 | 0.210 |
Why?
|
Quinine | 1 | 2002 | 1 | 0.210 |
Why?
|
Cross-Over Studies | 3 | 2013 | 80 | 0.210 |
Why?
|
Legislation, Hospital | 1 | 2001 | 1 | 0.200 |
Why?
|
Tooth Socket | 2 | 2013 | 2 | 0.200 |
Why?
|
Quality Improvement | 3 | 2018 | 158 | 0.200 |
Why?
|
Cooperative Behavior | 2 | 2016 | 87 | 0.200 |
Why?
|
Reproducibility of Results | 5 | 2014 | 802 | 0.200 |
Why?
|
Sucralfate | 2 | 1991 | 3 | 0.190 |
Why?
|
Peer Review, Health Care | 1 | 2001 | 1 | 0.190 |
Why?
|
APACHE | 3 | 2009 | 28 | 0.190 |
Why?
|
Professional Staff Committees | 1 | 2001 | 9 | 0.190 |
Why?
|
Selection Bias | 1 | 2001 | 10 | 0.190 |
Why?
|
Homosexuality, Male | 2 | 2020 | 24 | 0.190 |
Why?
|
Gammaproteobacteria | 1 | 2021 | 2 | 0.190 |
Why?
|
Spinal Puncture | 2 | 2000 | 27 | 0.190 |
Why?
|
Environmental Microbiology | 2 | 2017 | 4 | 0.190 |
Why?
|
Animals | 12 | 2017 | 4637 | 0.190 |
Why?
|
Clinical Protocols | 1 | 2021 | 64 | 0.190 |
Why?
|
Meningitis, Bacterial | 1 | 2000 | 8 | 0.190 |
Why?
|
Erythropoietin | 1 | 2001 | 55 | 0.180 |
Why?
|
Iatrogenic Disease | 1 | 2000 | 26 | 0.180 |
Why?
|
Emergency Service, Hospital | 3 | 2012 | 221 | 0.180 |
Why?
|
Health Status Disparities | 1 | 2021 | 69 | 0.180 |
Why?
|
Neutropenia | 3 | 2008 | 21 | 0.180 |
Why?
|
Enterococcus faecalis | 2 | 1997 | 7 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 6 | 1988 | 43 | 0.180 |
Why?
|
Staphylococcus | 5 | 1993 | 10 | 0.180 |
Why?
|
Fresh Water | 1 | 2020 | 4 | 0.180 |
Why?
|
Palliative Care | 1 | 2022 | 149 | 0.180 |
Why?
|
Klebsiella | 2 | 1999 | 2 | 0.180 |
Why?
|
Digestive System | 3 | 2000 | 16 | 0.180 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 969 | 0.180 |
Why?
|
Epidemiology | 2 | 1998 | 5 | 0.170 |
Why?
|
Lung | 2 | 1998 | 158 | 0.170 |
Why?
|
Risk Assessment | 4 | 2015 | 683 | 0.170 |
Why?
|
Mycobacterium tuberculosis | 2 | 1998 | 19 | 0.170 |
Why?
|
Proportional Hazards Models | 4 | 2019 | 346 | 0.170 |
Why?
|
Tobramycin | 2 | 1998 | 10 | 0.160 |
Why?
|
Hospital Bed Capacity, 500 and over | 3 | 2012 | 8 | 0.160 |
Why?
|
Drug Costs | 2 | 2010 | 17 | 0.160 |
Why?
|
Medical Errors | 1 | 2019 | 28 | 0.160 |
Why?
|
Workload | 2 | 2012 | 33 | 0.160 |
Why?
|
Species Specificity | 2 | 2016 | 73 | 0.160 |
Why?
|
Risk | 7 | 2003 | 216 | 0.160 |
Why?
|
Hygiene | 4 | 2019 | 13 | 0.160 |
Why?
|
Multilocus Sequence Typing | 4 | 2023 | 10 | 0.160 |
Why?
|
Practice Patterns, Physicians' | 4 | 2013 | 129 | 0.160 |
Why?
|
Genetic Variation | 3 | 2014 | 108 | 0.160 |
Why?
|
Sensitivity and Specificity | 5 | 2018 | 558 | 0.160 |
Why?
|
Consensus Development Conferences as Topic | 1 | 1998 | 4 | 0.160 |
Why?
|
Specialties, Nursing | 1 | 1998 | 10 | 0.160 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 16 | 0.150 |
Why?
|
Logistic Models | 7 | 2019 | 410 | 0.150 |
Why?
|
Zidovudine | 3 | 1992 | 40 | 0.150 |
Why?
|
HIV-1 | 4 | 1995 | 451 | 0.150 |
Why?
|
Prognosis | 7 | 2022 | 874 | 0.150 |
Why?
|
Tuberculosis | 2 | 1997 | 25 | 0.150 |
Why?
|
American Hospital Association | 2 | 1994 | 2 | 0.150 |
Why?
|
Fomites | 2 | 2008 | 4 | 0.150 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2017 | 6 | 0.150 |
Why?
|
Travel | 2 | 2014 | 14 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2016 | 399 | 0.150 |
Why?
|
Bone-Implant Interface | 1 | 2017 | 7 | 0.150 |
Why?
|
Preservation, Biological | 1 | 1997 | 4 | 0.150 |
Why?
|
Regression Analysis | 6 | 2019 | 298 | 0.150 |
Why?
|
Transfusion Reaction | 2 | 1995 | 9 | 0.150 |
Why?
|
Environment, Controlled | 1 | 2017 | 1 | 0.150 |
Why?
|
Greece | 1 | 2017 | 1 | 0.150 |
Why?
|
Feedback | 1 | 2017 | 32 | 0.150 |
Why?
|
Latin America | 1 | 2017 | 6 | 0.150 |
Why?
|
Israel | 1 | 2017 | 16 | 0.150 |
Why?
|
Endocarditis, Bacterial | 2 | 1996 | 10 | 0.140 |
Why?
|
Bacterial Translocation | 4 | 2001 | 35 | 0.140 |
Why?
|
Microbiology | 1 | 2016 | 2 | 0.140 |
Why?
|
Substance Abuse, Intravenous | 2 | 1996 | 12 | 0.140 |
Why?
|
Respiratory Tract Infections | 3 | 1996 | 22 | 0.140 |
Why?
|
Osseointegration | 1 | 2017 | 75 | 0.140 |
Why?
|
Health Care Surveys | 6 | 2014 | 67 | 0.140 |
Why?
|
Jurisprudence | 1 | 1996 | 3 | 0.140 |
Why?
|
Gloves, Surgical | 1 | 1996 | 7 | 0.140 |
Why?
|
Administration, Intranasal | 3 | 2023 | 25 | 0.140 |
Why?
|
Professional Role | 1 | 2016 | 27 | 0.140 |
Why?
|
Pregnancy | 2 | 2016 | 386 | 0.140 |
Why?
|
Pilot Projects | 4 | 2020 | 403 | 0.140 |
Why?
|
Gram-Positive Bacteria | 3 | 2012 | 16 | 0.140 |
Why?
|
Program Development | 1 | 2016 | 70 | 0.140 |
Why?
|
beta-Lactam Resistance | 3 | 2017 | 11 | 0.140 |
Why?
|
Sinus Floor Augmentation | 1 | 2016 | 1 | 0.140 |
Why?
|
Quinolones | 1 | 1996 | 22 | 0.140 |
Why?
|
Maxilla | 1 | 2016 | 2 | 0.140 |
Why?
|
Hydroxyapatites | 1 | 2016 | 9 | 0.140 |
Why?
|
Physician-Patient Relations | 1 | 1996 | 40 | 0.140 |
Why?
|
RNA, Bacterial | 1 | 2016 | 3 | 0.140 |
Why?
|
Nontuberculous Mycobacteria | 2 | 2015 | 5 | 0.140 |
Why?
|
Mycobacterium Infections, Nontuberculous | 2 | 2015 | 7 | 0.140 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 35 | 0.140 |
Why?
|
Titanium | 1 | 2017 | 197 | 0.140 |
Why?
|
Equipment and Supplies | 2 | 2010 | 14 | 0.130 |
Why?
|
Bone Matrix | 1 | 2016 | 28 | 0.130 |
Why?
|
Data Collection | 3 | 2006 | 108 | 0.130 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 1 | 1995 | 3 | 0.130 |
Why?
|
Histoplasmosis | 1 | 1995 | 8 | 0.130 |
Why?
|
Survival Analysis | 3 | 2008 | 310 | 0.130 |
Why?
|
HIV Seronegativity | 1 | 1996 | 43 | 0.130 |
Why?
|
Candidiasis | 1 | 2015 | 17 | 0.130 |
Why?
|
Poisson Distribution | 3 | 2015 | 25 | 0.130 |
Why?
|
Insurance, Health | 3 | 2003 | 22 | 0.130 |
Why?
|
Residence Characteristics | 2 | 2014 | 215 | 0.130 |
Why?
|
Thienamycins | 4 | 1998 | 6 | 0.130 |
Why?
|
Imipenem | 4 | 1998 | 7 | 0.130 |
Why?
|
Nystatin | 1 | 1995 | 2 | 0.130 |
Why?
|
Colistin | 1 | 1995 | 4 | 0.130 |
Why?
|
Interferon-alpha | 2 | 1992 | 69 | 0.130 |
Why?
|
Communication | 1 | 1996 | 111 | 0.130 |
Why?
|
Evidence-Based Medicine | 4 | 2008 | 214 | 0.130 |
Why?
|
Databases, Factual | 3 | 2019 | 331 | 0.130 |
Why?
|
Cluster Analysis | 5 | 2015 | 53 | 0.130 |
Why?
|
Dental Prosthesis Design | 2 | 2017 | 2 | 0.130 |
Why?
|
Severity of Illness Index | 8 | 2008 | 1126 | 0.130 |
Why?
|
Follow-Up Studies | 5 | 2019 | 1859 | 0.130 |
Why?
|
Tuberculin Test | 2 | 2009 | 12 | 0.130 |
Why?
|
Bacteriuria | 2 | 2015 | 5 | 0.130 |
Why?
|
Radiography | 2 | 2010 | 678 | 0.130 |
Why?
|
Terminally Ill | 1 | 2014 | 5 | 0.120 |
Why?
|
Emigrants and Immigrants | 1 | 2014 | 21 | 0.120 |
Why?
|
Cost Savings | 1 | 2014 | 35 | 0.120 |
Why?
|
Dental Plaque Index | 2 | 2004 | 2 | 0.120 |
Why?
|
Genetic Markers | 1 | 2014 | 45 | 0.120 |
Why?
|
Ventilator Weaning | 1 | 2015 | 35 | 0.120 |
Why?
|
Inpatients | 2 | 2009 | 141 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 51 | 0.120 |
Why?
|
Surgical Procedures, Operative | 4 | 2013 | 30 | 0.120 |
Why?
|
Breast Diseases | 1 | 1993 | 6 | 0.120 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2004 | 12 | 0.110 |
Why?
|
Blood | 2 | 2010 | 25 | 0.110 |
Why?
|
Soaps | 4 | 2010 | 9 | 0.110 |
Why?
|
Drug Prescriptions | 3 | 2003 | 35 | 0.110 |
Why?
|
Odds Ratio | 4 | 2021 | 286 | 0.110 |
Why?
|
Abscess | 1 | 1993 | 26 | 0.110 |
Why?
|
Models, Statistical | 4 | 2016 | 132 | 0.110 |
Why?
|
Heart Failure | 1 | 2016 | 207 | 0.110 |
Why?
|
Thailand | 1 | 2013 | 11 | 0.110 |
Why?
|
Drug Resistance | 2 | 2003 | 58 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2022 | 1462 | 0.110 |
Why?
|
Hospital Departments | 2 | 2002 | 9 | 0.110 |
Why?
|
Coronary Artery Bypass | 2 | 2011 | 31 | 0.110 |
Why?
|
Europe | 3 | 2014 | 85 | 0.100 |
Why?
|
Multicenter Studies as Topic | 3 | 2001 | 77 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2012 | 35 | 0.100 |
Why?
|
Epidemiologic Methods | 1 | 2012 | 20 | 0.100 |
Why?
|
Emotions | 1 | 2012 | 90 | 0.100 |
Why?
|
Anti-HIV Agents | 2 | 2006 | 173 | 0.100 |
Why?
|
Aspergillus niger | 1 | 1991 | 1 | 0.100 |
Why?
|
Charcoal | 1 | 1991 | 2 | 0.100 |
Why?
|
Paecilomyces | 1 | 1991 | 2 | 0.100 |
Why?
|
Penicillium | 1 | 1991 | 3 | 0.100 |
Why?
|
Pneumonia, Aspiration | 1 | 1991 | 6 | 0.100 |
Why?
|
Lung Diseases, Fungal | 1 | 1991 | 9 | 0.100 |
Why?
|
Aspergillosis | 1 | 1991 | 11 | 0.100 |
Why?
|
Models, Biological | 1 | 2014 | 347 | 0.100 |
Why?
|
Brucella | 1 | 2011 | 1 | 0.100 |
Why?
|
Brucellosis | 1 | 2011 | 1 | 0.100 |
Why?
|
Osteomyelitis | 2 | 2005 | 23 | 0.100 |
Why?
|
Quality Assurance, Health Care | 2 | 2010 | 48 | 0.100 |
Why?
|
HIV | 1 | 2012 | 92 | 0.100 |
Why?
|
Patient Readmission | 1 | 2012 | 124 | 0.100 |
Why?
|
Comorbidity | 3 | 2019 | 504 | 0.100 |
Why?
|
Serratia marcescens | 2 | 2010 | 11 | 0.100 |
Why?
|
Guided Tissue Regeneration, Periodontal | 1 | 2010 | 1 | 0.100 |
Why?
|
Peritoneal Diseases | 1 | 2010 | 4 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 1991 | 43 | 0.090 |
Why?
|
Medical Office Buildings | 1 | 2010 | 1 | 0.090 |
Why?
|
Oropharynx | 1 | 1990 | 2 | 0.090 |
Why?
|
Surveys and Questionnaires | 3 | 2015 | 1187 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2012 | 117 | 0.090 |
Why?
|
Efficiency | 1 | 2010 | 15 | 0.090 |
Why?
|
beta-Lactams | 3 | 2007 | 7 | 0.090 |
Why?
|
Blood Platelets | 1 | 2010 | 50 | 0.090 |
Why?
|
Cephalosporin Resistance | 2 | 2001 | 2 | 0.090 |
Why?
|
Pancreatitis, Acute Necrotizing | 2 | 2001 | 4 | 0.090 |
Why?
|
Serratia | 3 | 2010 | 7 | 0.090 |
Why?
|
Medicare | 1 | 2011 | 123 | 0.090 |
Why?
|
Ecosystem | 2 | 2021 | 27 | 0.090 |
Why?
|
Dental Abutments | 1 | 2010 | 1 | 0.090 |
Why?
|
Dental Restoration, Temporary | 1 | 2010 | 1 | 0.090 |
Why?
|
Dental Prosthesis Retention | 1 | 2010 | 1 | 0.090 |
Why?
|
Dental Restoration Failure | 1 | 2010 | 2 | 0.090 |
Why?
|
Knowledge Bases | 1 | 2010 | 3 | 0.090 |
Why?
|
Computer-Aided Design | 1 | 2010 | 16 | 0.090 |
Why?
|
Azlocillin | 1 | 1989 | 1 | 0.090 |
Why?
|
Drug Administration Schedule | 3 | 2008 | 232 | 0.090 |
Why?
|
Lice Infestations | 1 | 1989 | 2 | 0.090 |
Why?
|
Urethral Diseases | 1 | 1989 | 4 | 0.090 |
Why?
|
Hospitals, Special | 1 | 2009 | 6 | 0.090 |
Why?
|
Substance-Related Disorders | 4 | 2015 | 104 | 0.090 |
Why?
|
Linear Models | 1 | 2010 | 258 | 0.090 |
Why?
|
Organizational Policy | 1 | 2009 | 15 | 0.090 |
Why?
|
Patient Care Planning | 2 | 1995 | 56 | 0.090 |
Why?
|
Fever | 1 | 1989 | 40 | 0.090 |
Why?
|
Ventilators, Negative-Pressure | 1 | 2009 | 1 | 0.080 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 532 | 0.080 |
Why?
|
Patient Admission | 2 | 2002 | 30 | 0.080 |
Why?
|
Urinary Catheterization | 2 | 2008 | 6 | 0.080 |
Why?
|
Electronic Health Records | 1 | 2010 | 66 | 0.080 |
Why?
|
Surgical Flaps | 2 | 2013 | 50 | 0.080 |
Why?
|
Acute Disease | 4 | 2023 | 225 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2010 | 75 | 0.080 |
Why?
|
False Positive Reactions | 3 | 1998 | 34 | 0.080 |
Why?
|
Sputum | 3 | 2015 | 23 | 0.080 |
Why?
|
Cefotaxime | 2 | 1986 | 5 | 0.080 |
Why?
|
Molecular Sequence Data | 2 | 2014 | 245 | 0.080 |
Why?
|
Pancreatitis | 2 | 2000 | 25 | 0.080 |
Why?
|
Foodborne Diseases | 1 | 2008 | 3 | 0.080 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2013 | 221 | 0.080 |
Why?
|
Lactams | 2 | 2005 | 5 | 0.080 |
Why?
|
Los Angeles | 5 | 2000 | 7 | 0.080 |
Why?
|
Antisepsis | 3 | 2003 | 3 | 0.080 |
Why?
|
Bedding and Linens | 1 | 2007 | 4 | 0.080 |
Why?
|
Folliculitis | 1 | 1987 | 1 | 0.080 |
Why?
|
Porifera | 1 | 1987 | 1 | 0.080 |
Why?
|
Statistics, Nonparametric | 2 | 2004 | 137 | 0.080 |
Why?
|
Renal Dialysis | 2 | 2015 | 110 | 0.070 |
Why?
|
Random Allocation | 4 | 2000 | 143 | 0.070 |
Why?
|
Health Facilities | 1 | 2007 | 18 | 0.070 |
Why?
|
Software | 2 | 2006 | 72 | 0.070 |
Why?
|
Cost Control | 1 | 2006 | 11 | 0.070 |
Why?
|
Inservice Training | 1 | 2006 | 26 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2010 | 297 | 0.070 |
Why?
|
Aging | 1 | 1996 | 1630 | 0.070 |
Why?
|
Neoplasms | 1 | 1989 | 257 | 0.070 |
Why?
|
Carbon | 1 | 2006 | 9 | 0.070 |
Why?
|
Platinum | 1 | 2006 | 5 | 0.070 |
Why?
|
Contact Tracing | 2 | 2011 | 6 | 0.070 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2005 | 4 | 0.070 |
Why?
|
Age Factors | 3 | 2004 | 853 | 0.070 |
Why?
|
Sex Factors | 3 | 2015 | 497 | 0.070 |
Why?
|
Quality of Life | 1 | 2010 | 677 | 0.070 |
Why?
|
Bronchoscopy | 4 | 2003 | 25 | 0.070 |
Why?
|
Survival Rate | 3 | 2003 | 376 | 0.060 |
Why?
|
Aminoglycosides | 6 | 1987 | 11 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2006 | 43 | 0.060 |
Why?
|
AIDS Serodiagnosis | 1 | 2005 | 6 | 0.060 |
Why?
|
Societies, Medical | 1 | 2006 | 190 | 0.060 |
Why?
|
Treatment Failure | 1 | 2005 | 161 | 0.060 |
Why?
|
Sexually Transmitted Diseases | 1 | 2005 | 16 | 0.060 |
Why?
|
Tooth Discoloration | 1 | 2004 | 1 | 0.060 |
Why?
|
Dental Implantation | 1 | 2004 | 2 | 0.060 |
Why?
|
Lumbosacral Region | 1 | 2005 | 73 | 0.060 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2004 | 19 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2001 | 258 | 0.060 |
Why?
|
Analysis of Variance | 3 | 2017 | 325 | 0.060 |
Why?
|
Zoonoses | 1 | 2004 | 9 | 0.060 |
Why?
|
Health Planning | 1 | 2004 | 5 | 0.060 |
Why?
|
Patient Participation | 1 | 2005 | 51 | 0.060 |
Why?
|
Sanitary Engineering | 1 | 1984 | 1 | 0.060 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2004 | 6 | 0.060 |
Why?
|
Transducers | 3 | 1986 | 10 | 0.060 |
Why?
|
Research Design | 1 | 2006 | 214 | 0.060 |
Why?
|
Tooth Root | 1 | 2004 | 1 | 0.060 |
Why?
|
Edetic Acid | 1 | 2004 | 3 | 0.060 |
Why?
|
Periodontal Index | 1 | 2004 | 2 | 0.060 |
Why?
|
Periodontal Pocket | 1 | 2004 | 2 | 0.060 |
Why?
|
Periodontal Attachment Loss | 1 | 2004 | 3 | 0.060 |
Why?
|
Chelating Agents | 1 | 2004 | 11 | 0.060 |
Why?
|
Sentinel Surveillance | 1 | 2003 | 8 | 0.060 |
Why?
|
Radiology Information Systems | 1 | 2003 | 3 | 0.060 |
Why?
|
Pancreatic Diseases | 1 | 1983 | 2 | 0.060 |
Why?
|
Pragmatic Clinical Trials as Topic | 1 | 2023 | 3 | 0.060 |
Why?
|
Quarantine | 1 | 2023 | 3 | 0.060 |
Why?
|
History, 20th Century | 2 | 2013 | 91 | 0.060 |
Why?
|
Monitoring, Physiologic | 3 | 1986 | 93 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2004 | 79 | 0.060 |
Why?
|
Obstetrics and Gynecology Department, Hospital | 1 | 1983 | 4 | 0.060 |
Why?
|
Database Management Systems | 1 | 2003 | 1 | 0.060 |
Why?
|
Blood-Borne Pathogens | 1 | 2003 | 3 | 0.060 |
Why?
|
Computer Systems | 1 | 2003 | 5 | 0.060 |
Why?
|
Computer Communication Networks | 1 | 2003 | 4 | 0.060 |
Why?
|
Sarcoidosis | 1 | 1983 | 14 | 0.060 |
Why?
|
Infant, Newborn, Diseases | 1 | 1983 | 17 | 0.060 |
Why?
|
Models, Theoretical | 2 | 2021 | 94 | 0.060 |
Why?
|
Facility Design and Construction | 1 | 2003 | 1 | 0.060 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1983 | 30 | 0.060 |
Why?
|
Hospitals, Community | 1 | 2003 | 14 | 0.050 |
Why?
|
Bone Regeneration | 1 | 2004 | 75 | 0.050 |
Why?
|
Kidney Function Tests | 1 | 2002 | 23 | 0.050 |
Why?
|
Contraindications | 1 | 2002 | 42 | 0.050 |
Why?
|
Fatigue | 1 | 2023 | 63 | 0.050 |
Why?
|
Hospitals, Municipal | 1 | 2002 | 1 | 0.050 |
Why?
|
Patient Compliance | 1 | 2004 | 165 | 0.050 |
Why?
|
Pneumococcal Infections | 1 | 2002 | 9 | 0.050 |
Why?
|
Home Care Services | 1 | 2002 | 21 | 0.050 |
Why?
|
New York City | 2 | 2000 | 18 | 0.050 |
Why?
|
Deoxycholic Acid | 1 | 2002 | 3 | 0.050 |
Why?
|
Blood Pressure Determination | 2 | 1986 | 21 | 0.050 |
Why?
|
Medication Errors | 1 | 2002 | 16 | 0.050 |
Why?
|
Therapies, Investigational | 1 | 2022 | 7 | 0.050 |
Why?
|
Sequence Analysis, RNA | 1 | 2002 | 43 | 0.050 |
Why?
|
Base Sequence | 1 | 2002 | 133 | 0.050 |
Why?
|
Animal Husbandry | 1 | 2001 | 6 | 0.050 |
Why?
|
North America | 1 | 2001 | 39 | 0.050 |
Why?
|
Gift Giving | 1 | 2021 | 1 | 0.050 |
Why?
|
Hand Sanitizers | 1 | 2021 | 1 | 0.050 |
Why?
|
Social Determinants of Health | 1 | 2022 | 27 | 0.050 |
Why?
|
Polymerase Chain Reaction | 3 | 2016 | 164 | 0.050 |
Why?
|
Intestinal Mucosa | 2 | 2001 | 224 | 0.050 |
Why?
|
Methicillin | 1 | 2021 | 6 | 0.050 |
Why?
|
Anticoagulants | 1 | 2002 | 102 | 0.050 |
Why?
|
Glucagon | 1 | 2001 | 6 | 0.050 |
Why?
|
Epoetin Alfa | 1 | 2001 | 20 | 0.050 |
Why?
|
Confidentiality | 1 | 2001 | 11 | 0.050 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2001 | 5 | 0.050 |
Why?
|
Employment | 1 | 2021 | 42 | 0.050 |
Why?
|
Health Surveys | 1 | 2021 | 96 | 0.050 |
Why?
|
Lung Diseases | 2 | 1998 | 46 | 0.050 |
Why?
|
Meningitis | 2 | 1984 | 11 | 0.050 |
Why?
|
Health Education | 1 | 2001 | 41 | 0.050 |
Why?
|
Geography | 2 | 2011 | 22 | 0.050 |
Why?
|
Peptides | 1 | 2001 | 98 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2001 | 177 | 0.050 |
Why?
|
Waste Disposal, Fluid | 1 | 2020 | 2 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2020 | 9 | 0.040 |
Why?
|
California | 1 | 2019 | 31 | 0.040 |
Why?
|
Lumbar Vertebrae | 1 | 2005 | 490 | 0.040 |
Why?
|
Respiratory Insufficiency | 1 | 2000 | 50 | 0.040 |
Why?
|
Disease Progression | 1 | 2022 | 812 | 0.040 |
Why?
|
Computer Simulation | 1 | 2021 | 218 | 0.040 |
Why?
|
Interleukin-6 | 1 | 2000 | 109 | 0.040 |
Why?
|
Platelet Activating Factor | 1 | 1999 | 8 | 0.040 |
Why?
|
Leucine | 1 | 1999 | 15 | 0.040 |
Why?
|
Enteral Nutrition | 2 | 1998 | 50 | 0.040 |
Why?
|
Biopsy | 2 | 2017 | 239 | 0.040 |
Why?
|
Bias | 1 | 1999 | 34 | 0.040 |
Why?
|
Homes for the Aged | 1 | 1999 | 9 | 0.040 |
Why?
|
Haemophilus influenzae | 1 | 1999 | 1 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1998 | 7 | 0.040 |
Why?
|
Academic Medical Centers | 2 | 2010 | 142 | 0.040 |
Why?
|
Ear, Middle | 1 | 1999 | 8 | 0.040 |
Why?
|
Leukemia, Hairy Cell | 1 | 1978 | 1 | 0.040 |
Why?
|
ROC Curve | 1 | 2019 | 140 | 0.040 |
Why?
|
Imidazoles | 1 | 1999 | 72 | 0.040 |
Why?
|
Statistics as Topic | 1 | 1998 | 114 | 0.040 |
Why?
|
Homosexuality | 2 | 1995 | 9 | 0.040 |
Why?
|
Patient Reported Outcome Measures | 1 | 2022 | 384 | 0.040 |
Why?
|
Societies, Scientific | 1 | 1998 | 12 | 0.040 |
Why?
|
Patient Care Management | 1 | 1998 | 18 | 0.040 |
Why?
|
Hemodynamics | 1 | 1998 | 90 | 0.040 |
Why?
|
Gram-Positive Cocci | 2 | 2008 | 5 | 0.040 |
Why?
|
Nebulizers and Vaporizers | 1 | 1998 | 15 | 0.040 |
Why?
|
Hepatitis B | 2 | 1981 | 18 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2019 | 161 | 0.040 |
Why?
|
Acid Etching, Dental | 1 | 2017 | 2 | 0.040 |
Why?
|
Dental Alloys | 1 | 2017 | 4 | 0.040 |
Why?
|
Virus Diseases | 1 | 1997 | 16 | 0.040 |
Why?
|
Evidence-Based Practice | 1 | 2018 | 77 | 0.040 |
Why?
|
Clinical Studies as Topic | 1 | 2017 | 3 | 0.040 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2017 | 77 | 0.040 |
Why?
|
Mycoses | 1 | 1997 | 22 | 0.040 |
Why?
|
Freezing | 1 | 1997 | 13 | 0.040 |
Why?
|
Swine | 1 | 2017 | 83 | 0.040 |
Why?
|
Agranulocytosis | 2 | 1989 | 5 | 0.040 |
Why?
|
Temperature | 1 | 2017 | 74 | 0.040 |
Why?
|
Implants, Experimental | 1 | 2017 | 31 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 1997 | 32 | 0.040 |
Why?
|
Surface Properties | 1 | 2017 | 133 | 0.040 |
Why?
|
Research Personnel | 1 | 2017 | 21 | 0.040 |
Why?
|
Models, Animal | 1 | 2017 | 128 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2012 | 96 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 1996 | 6 | 0.040 |
Why?
|
Product Surveillance, Postmarketing | 1 | 1996 | 17 | 0.040 |
Why?
|
Genes, Bacterial | 1 | 2016 | 6 | 0.040 |
Why?
|
Selection, Genetic | 1 | 2016 | 6 | 0.040 |
Why?
|
Hospitals, Veterans | 1 | 1996 | 6 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 1996 | 6 | 0.030 |
Why?
|
Materials Testing | 1 | 2017 | 136 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 56 | 0.030 |
Why?
|
Ampicillin | 1 | 1996 | 7 | 0.030 |
Why?
|
Teicoplanin | 1 | 1996 | 5 | 0.030 |
Why?
|
Age Distribution | 1 | 1996 | 95 | 0.030 |
Why?
|
Sex Distribution | 1 | 1996 | 86 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 1996 | 44 | 0.030 |
Why?
|
Sternum | 1 | 1976 | 5 | 0.030 |
Why?
|
Mediastinitis | 1 | 1976 | 6 | 0.030 |
Why?
|
Ceramics | 1 | 2016 | 23 | 0.030 |
Why?
|
Bacterial Adhesion | 1 | 1996 | 5 | 0.030 |
Why?
|
Bone Substitutes | 1 | 2016 | 26 | 0.030 |
Why?
|
Leadership | 1 | 2017 | 96 | 0.030 |
Why?
|
Histoplasma | 1 | 1995 | 3 | 0.030 |
Why?
|
Insurance, Hospitalization | 1 | 1995 | 2 | 0.030 |
Why?
|
Mucous Membrane | 1 | 1996 | 40 | 0.030 |
Why?
|
Candida | 1 | 2015 | 16 | 0.030 |
Why?
|
Cattle | 1 | 2016 | 219 | 0.030 |
Why?
|
Guatemala | 1 | 1995 | 1 | 0.030 |
Why?
|
Diffusion | 2 | 2014 | 28 | 0.030 |
Why?
|
Cytokines | 1 | 1998 | 350 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 1996 | 157 | 0.030 |
Why?
|
Bisexuality | 1 | 1995 | 7 | 0.030 |
Why?
|
Urban Health Services | 1 | 2015 | 13 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2015 | 8 | 0.030 |
Why?
|
Staining and Labeling | 1 | 1975 | 21 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 1975 | 19 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2016 | 105 | 0.030 |
Why?
|
Markov Chains | 1 | 2015 | 29 | 0.030 |
Why?
|
Florida | 4 | 1995 | 21 | 0.030 |
Why?
|
Osteogenesis | 1 | 2016 | 103 | 0.030 |
Why?
|
Coagulase | 2 | 1993 | 2 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2015 | 53 | 0.030 |
Why?
|
Pulmonary Atelectasis | 1 | 2015 | 4 | 0.030 |
Why?
|
Gastric Juice | 1 | 2015 | 3 | 0.030 |
Why?
|
Drinking Water | 1 | 2015 | 3 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2015 | 16 | 0.030 |
Why?
|
Pentazocine | 2 | 1985 | 2 | 0.030 |
Why?
|
Tripelennamine | 2 | 1985 | 2 | 0.030 |
Why?
|
Syria | 1 | 2014 | 1 | 0.030 |
Why?
|
Management Audit | 1 | 2014 | 2 | 0.030 |
Why?
|
Tibia | 1 | 2017 | 266 | 0.030 |
Why?
|
Minority Groups | 1 | 1995 | 67 | 0.030 |
Why?
|
Forecasting | 1 | 1995 | 117 | 0.030 |
Why?
|
Thromboembolism | 1 | 2015 | 19 | 0.030 |
Why?
|
Epidemiological Monitoring | 1 | 2014 | 7 | 0.030 |
Why?
|
Virulence Factors | 1 | 2014 | 10 | 0.030 |
Why?
|
Pulmonary Edema | 1 | 2015 | 18 | 0.030 |
Why?
|
Delirium | 1 | 2015 | 36 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 1995 | 103 | 0.030 |
Why?
|
Hand Hygiene | 1 | 2014 | 2 | 0.030 |
Why?
|
United States Occupational Safety and Health Administration | 1 | 1994 | 1 | 0.030 |
Why?
|
Organizational Culture | 1 | 2014 | 19 | 0.030 |
Why?
|
Planning Techniques | 1 | 1994 | 13 | 0.030 |
Why?
|
Chickens | 1 | 2014 | 20 | 0.030 |
Why?
|
Campylobacter Infections | 1 | 2014 | 11 | 0.030 |
Why?
|
Focus Groups | 1 | 2014 | 85 | 0.030 |
Why?
|
Longevity | 1 | 2014 | 32 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 2001 | 463 | 0.030 |
Why?
|
Nafcillin | 1 | 1993 | 1 | 0.030 |
Why?
|
Clindamycin | 1 | 1993 | 3 | 0.030 |
Why?
|
History, 21st Century | 1 | 2013 | 37 | 0.030 |
Why?
|
Drug Discovery | 1 | 2013 | 21 | 0.030 |
Why?
|
Double-Blind Method | 1 | 1995 | 522 | 0.030 |
Why?
|
Qualitative Research | 1 | 2014 | 113 | 0.030 |
Why?
|
Publishing | 1 | 1994 | 38 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2013 | 7 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2015 | 182 | 0.030 |
Why?
|
Drainage | 1 | 1993 | 50 | 0.030 |
Why?
|
Alveolar Process | 1 | 2013 | 1 | 0.030 |
Why?
|
Alveolar Ridge Augmentation | 1 | 2013 | 1 | 0.030 |
Why?
|
Periodontium | 1 | 2013 | 1 | 0.030 |
Why?
|
Esthetics, Dental | 1 | 2013 | 2 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 1993 | 102 | 0.030 |
Why?
|
Indiana | 2 | 2011 | 17 | 0.030 |
Why?
|
Rats | 3 | 2001 | 876 | 0.030 |
Why?
|
Propensity Score | 1 | 2012 | 34 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 177 | 0.030 |
Why?
|
HIV Core Protein p24 | 1 | 1992 | 29 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 1992 | 98 | 0.030 |
Why?
|
Lung Diseases, Obstructive | 1 | 1991 | 6 | 0.030 |
Why?
|
Biomarkers | 1 | 2015 | 704 | 0.030 |
Why?
|
Splenomegaly | 1 | 2011 | 3 | 0.020 |
Why?
|
Milk | 1 | 2011 | 9 | 0.020 |
Why?
|
Hepatomegaly | 1 | 2011 | 4 | 0.020 |
Why?
|
Virulence | 1 | 2011 | 15 | 0.020 |
Why?
|
Gastric Acidity Determination | 1 | 1991 | 2 | 0.020 |
Why?
|
Mexico | 1 | 2011 | 17 | 0.020 |
Why?
|
Insurance Claim Reporting | 1 | 2011 | 1 | 0.020 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2011 | 9 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 1991 | 45 | 0.020 |
Why?
|
Administration, Topical | 1 | 1991 | 18 | 0.020 |
Why?
|
Prednisone | 1 | 1991 | 68 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 5 | 0.020 |
Why?
|
Clone Cells | 1 | 2011 | 22 | 0.020 |
Why?
|
Gene Frequency | 1 | 2011 | 72 | 0.020 |
Why?
|
Syringes | 1 | 2010 | 11 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 2011 | 59 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1993 | 201 | 0.020 |
Why?
|
Bone Transplantation | 1 | 2013 | 227 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2010 | 48 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2010 | 120 | 0.020 |
Why?
|
Recurrence | 1 | 2011 | 354 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2010 | 130 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 1991 | 194 | 0.020 |
Why?
|
Automation | 1 | 2010 | 11 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2010 | 10 | 0.020 |
Why?
|
Genitalia, Male | 1 | 1989 | 1 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 1991 | 337 | 0.020 |
Why?
|
Ileum | 2 | 2001 | 24 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2010 | 102 | 0.020 |
Why?
|
Interferon Type I | 1 | 1989 | 19 | 0.020 |
Why?
|
Mutation | 3 | 1986 | 397 | 0.020 |
Why?
|
Escherichia coli O157 | 1 | 2008 | 2 | 0.020 |
Why?
|
Salmonella | 1 | 2008 | 5 | 0.020 |
Why?
|
Citrobacter | 1 | 1987 | 1 | 0.020 |
Why?
|
Oxacillin | 1 | 1987 | 2 | 0.020 |
Why?
|
Lymph Nodes | 2 | 1999 | 71 | 0.020 |
Why?
|
Drug Administration Routes | 1 | 2006 | 12 | 0.020 |
Why?
|
Allied Health Personnel | 1 | 2006 | 12 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2006 | 51 | 0.020 |
Why?
|
Transducers, Pressure | 1 | 1986 | 4 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2006 | 8 | 0.020 |
Why?
|
Nurses | 1 | 2006 | 46 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 1991 | 636 | 0.020 |
Why?
|
Diphtheria | 1 | 1985 | 1 | 0.020 |
Why?
|
Georgia | 2 | 1976 | 12 | 0.020 |
Why?
|
Patients | 1 | 2006 | 31 | 0.020 |
Why?
|
Penicillanic Acid | 1 | 2005 | 3 | 0.020 |
Why?
|
Piperacillin | 1 | 2005 | 3 | 0.020 |
Why?
|
Ceftriaxone | 1 | 2005 | 5 | 0.020 |
Why?
|
Metronidazole | 1 | 2005 | 8 | 0.020 |
Why?
|
Deltaretrovirus | 1 | 1985 | 1 | 0.020 |
Why?
|
Blood Donors | 1 | 1985 | 5 | 0.020 |
Why?
|
Digestive System Surgical Procedures | 1 | 2005 | 20 | 0.020 |
Why?
|
Serotyping | 4 | 1987 | 12 | 0.020 |
Why?
|
Infant, Premature | 1 | 1986 | 184 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2004 | 11 | 0.010 |
Why?
|
Ibuprofen | 1 | 1984 | 12 | 0.010 |
Why?
|
Moxalactam | 1 | 1983 | 1 | 0.010 |
Why?
|
Cefoxitin | 1 | 1983 | 2 | 0.010 |
Why?
|
Milk, Human | 1 | 1986 | 157 | 0.010 |
Why?
|
Nurseries, Hospital | 1 | 1983 | 4 | 0.010 |
Why?
|
Echinococcosis, Hepatic | 1 | 1983 | 1 | 0.010 |
Why?
|
Echinococcosis, Pulmonary | 1 | 1983 | 1 | 0.010 |
Why?
|
Mebendazole | 1 | 1983 | 1 | 0.010 |
Why?
|
Eosinophilia | 1 | 1984 | 47 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1983 | 10 | 0.010 |
Why?
|
Policy Making | 1 | 1983 | 15 | 0.010 |
Why?
|
Benzimidazoles | 1 | 1983 | 11 | 0.010 |
Why?
|
Resource Allocation | 1 | 2003 | 5 | 0.010 |
Why?
|
Blood Pressure Monitors | 1 | 2002 | 1 | 0.010 |
Why?
|
Umbilical Arteries | 1 | 2002 | 2 | 0.010 |
Why?
|
R Factors | 1 | 1982 | 2 | 0.010 |
Why?
|
Patient Selection | 1 | 2004 | 234 | 0.010 |
Why?
|
Disease Reservoirs | 1 | 2002 | 10 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 1981 | 4 | 0.010 |
Why?
|
Malaria | 1 | 1981 | 6 | 0.010 |
Why?
|
Glucagon-Like Peptides | 1 | 2001 | 2 | 0.010 |
Why?
|
Glucagon-Like Peptide 2 | 1 | 2001 | 2 | 0.010 |
Why?
|
Jejunum | 1 | 2001 | 12 | 0.010 |
Why?
|
Breast Feeding | 1 | 1983 | 155 | 0.010 |
Why?
|
Permeability | 1 | 2001 | 139 | 0.010 |
Why?
|
Conjugation, Genetic | 2 | 1996 | 5 | 0.010 |
Why?
|
Weight Loss | 1 | 2001 | 101 | 0.010 |
Why?
|
Cecum | 1 | 2000 | 7 | 0.010 |
Why?
|
Blood Cell Count | 1 | 2000 | 16 | 0.010 |
Why?
|
Netilmicin | 1 | 1980 | 1 | 0.010 |
Why?
|
Pseudomonadaceae | 1 | 1980 | 1 | 0.010 |
Why?
|
Urine | 1 | 1980 | 9 | 0.010 |
Why?
|
Pancreas | 1 | 2000 | 34 | 0.010 |
Why?
|
Dogs | 1 | 2000 | 261 | 0.010 |
Why?
|
Amylases | 1 | 1999 | 4 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2000 | 125 | 0.010 |
Why?
|
Rheumatic Fever | 1 | 1979 | 1 | 0.010 |
Why?
|
Gonorrhea | 1 | 1979 | 8 | 0.010 |
Why?
|
Carbon-Oxygen Ligases | 1 | 1999 | 2 | 0.010 |
Why?
|
Haemophilus Infections | 1 | 1999 | 2 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1985 | 957 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1999 | 223 | 0.010 |
Why?
|
Leukemia, Lymphoid | 1 | 1978 | 2 | 0.010 |
Why?
|
Gastroenteritis | 1 | 1977 | 3 | 0.010 |
Why?
|
Cefazolin | 2 | 1988 | 5 | 0.010 |
Why?
|
Hepatitis | 1 | 1977 | 9 | 0.010 |
Why?
|
Skin Diseases, Infectious | 1 | 1977 | 9 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 1977 | 40 | 0.010 |
Why?
|
Mesentery | 1 | 1997 | 5 | 0.010 |
Why?
|
Serum Albumin, Bovine | 1 | 1997 | 8 | 0.010 |
Why?
|
Laparotomy | 1 | 1997 | 22 | 0.010 |
Why?
|
Proteins | 1 | 1997 | 71 | 0.010 |
Why?
|
Sterilization | 1 | 1976 | 10 | 0.010 |
Why?
|
Pseudomonas | 1 | 1976 | 1 | 0.010 |
Why?
|
Sexual Behavior | 1 | 1996 | 67 | 0.010 |
Why?
|
Saphenous Vein | 1 | 1976 | 9 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1975 | 14 | 0.010 |
Why?
|
North Carolina | 1 | 1995 | 5 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1976 | 197 | 0.010 |
Why?
|
Culture Techniques | 1 | 1975 | 24 | 0.010 |
Why?
|
Laboratories | 1 | 1975 | 26 | 0.010 |
Why?
|
Leukocytes | 1 | 1975 | 45 | 0.010 |
Why?
|
Veterans | 1 | 1995 | 63 | 0.010 |
Why?
|
Liver | 1 | 1975 | 175 | 0.010 |
Why?
|
Isoelectric Focusing | 1 | 1993 | 4 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1993 | 33 | 0.010 |
Why?
|
Kinetics | 1 | 1993 | 230 | 0.010 |
Why?
|
AIDS-Related Complex | 1 | 1992 | 3 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1992 | 35 | 0.010 |
Why?
|
Leukocyte Count | 1 | 1992 | 92 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1992 | 95 | 0.010 |
Why?
|
DNA, Viral | 1 | 1992 | 98 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1992 | 223 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1989 | 56 | 0.010 |
Why?
|
Peritoneum | 1 | 1986 | 18 | 0.000 |
Why?
|
Disposable Equipment | 1 | 1986 | 2 | 0.000 |
Why?
|
Diphtheria Toxoid | 1 | 1985 | 1 | 0.000 |
Why?
|
Immunization, Secondary | 1 | 1985 | 7 | 0.000 |
Why?
|
Immunization | 1 | 1985 | 47 | 0.000 |
Why?
|
Seasons | 1 | 1985 | 31 | 0.000 |
Why?
|
Viremia | 1 | 1985 | 37 | 0.000 |
Why?
|
HIV Antibodies | 1 | 1985 | 42 | 0.000 |
Why?
|
Cardiac Catheterization | 1 | 1986 | 93 | 0.000 |
Why?
|
Drug Interactions | 1 | 1985 | 68 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1985 | 89 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1984 | 58 | 0.000 |
Why?
|
Cefamandole | 1 | 1983 | 1 | 0.000 |
Why?
|
Hydrolysis | 1 | 1983 | 10 | 0.000 |
Why?
|
Bone Marrow | 1 | 1983 | 78 | 0.000 |
Why?
|
Africa, Eastern | 1 | 1981 | 1 | 0.000 |
Why?
|
Proteus Infections | 1 | 1976 | 1 | 0.000 |
Why?
|